HIGHLIGHTS
- who: Taiyu Zhai and colleagues from the Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China have published the research work: Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment, in the Journal: Oxidative Medicine and Cellular Longevity of 24/09/2022
SUMMARY
Atherosclerosis (AS) is a chronic inflammatory disease caused by metabolic disorders, which has been recognized by most experts in this field. In the study of Mitra et_al, the nucleic_acid component of probiotic Lactobacillus rhamnosus was detected in atherosclerotic plaques and was greatly enriched in stable plaques, suggesting . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.